<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-EC3SGK0H</identifier><date>2019</date><creator>Ivanuš, Urška</creator><creator>Jerman, Tine</creator><creator>Kloboves-Prevodnik, Veronika</creator><creator>Oštrbenk Valenčak, Anja</creator><creator>Pohar-Marinšek, Živa</creator><creator>Poljak, Mario</creator><creator>Varl, Jerneja</creator><relation>documents/doc/E/URN_NBN_SI_doc-EC3SGK0H_001.pdf</relation><relation>documents/doc/E/URN_NBN_SI_doc-EC3SGK0H_001.txt</relation><format format_type="issue">3</format><format format_type="volume">53</format><format format_type="type">article</format><format format_type="extent">str. 316-322, IV</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">3359355</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-EC3SGK0H</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">HPV test</subject><subject language_type_id="slv">maternični vrat</subject><subject language_type_id="slv">mejni rezultati</subject><subject language_type_id="slv">presejalni testi</subject><subject language_type_id="slv">rak (medicina)</subject><title>Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium</title></Record>